Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer. - Mahasongkram K; Glab-Ampai K; Kaewchim K; Saenlom T; Chulanetra M; Sookrung N; Nathalang O; Chaicumpa W (Vaccines, 2023)